CIK 0001641281 · <br>Emerging growth company
Bolt Biotherapeutics, Inc.
Sign in to watch- Ticker
- BOLT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 472804636
- Phone
- 650-665-9295
- Business address
- 900 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
- Former names
- Bolt Therapeutics, Inc.
- 4 Open-market buy 10% owner bought 50,000 shares at $6.38 ($319,000)
- 3 Insider Initial Statement of Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Grant or award Chief Strategy Officer acquired 85,821 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 8-K Event Material agreement · Agreement ended · Acquisition or sale completed · Unregistered share sale · Executive or director change · Bylaws or fiscal year change · Regulation FD disclosure · Other events
- 8-K Event Material agreement
- 4 Open-market sale Chief Operating Officer sold 13,176 shares at an average $3.32 ($43,807)
- 4 Open-market sale Senior VP, Finance and PAO sold 7,842 shares at an average $3.32 ($26,072)
- 4 Open-market sale President, CEO and CFO sold 17,566 shares at an average $3.32 ($58,402)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- 10-Q Report Quarterly Report
Page 1 of 15 · 297 filings